Financial results - BIOACCENT SRL

Financial Summary - Bioaccent Srl
Unique identification code: 35629683
Registration number: J24/200/2016
Nace: 4638
Sales - Ron
293.515
Net Profit - Ron
69.685
Employee
2
The most important financial indicators for the company Bioaccent Srl - Unique Identification Number 35629683: sales in 2023 was 293.515 euro, registering a net profit of 69.685 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata specializat al altor alimente, inclusiv peste, crustacee si moluste having the NACE code 4638.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Bioaccent Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 14.521 52.892 107.107 93.379 152.088 257.289 204.535 293.515
Total Income - EUR - - 14.688 53.722 107.493 94.104 154.046 257.525 206.615 364.806
Total Expenses - EUR - - 16.702 44.083 83.104 72.931 106.950 179.656 177.626 292.539
Gross Profit/Loss - EUR - - -2.014 9.639 24.389 21.172 47.096 77.869 28.989 72.268
Net Profit/Loss - EUR - - -2.450 8.053 22.814 20.232 45.691 75.603 27.243 69.685
Employees - - 1 1 1 1 1 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 43.9%, from 204.535 euro in the year 2022, to 293.515 euro in 2023. The Net Profit increased by 42.525 euro, from 27.243 euro in 2022, to 69.685 in the last year.

Check the financial reports for the company - Bioaccent Srl

Rating financiar

Financial Rating -
Bioaccent Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Bioaccent Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bioaccent Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Bioaccent Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bioaccent Srl - CUI 35629683

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 347 2.738 2.784 2.110 25.737 19.042 23.620 15.279
Current Assets - - 6.321 14.982 32.095 42.556 59.304 117.340 111.891 185.489
Inventories - - 1.964 12.975 4.317 3.141 18.017 12.560 38.189 36.313
Receivables - - 1.324 1.087 9.417 4.417 4.696 31.014 47.479 111.716
Cash - - 3.034 920 18.361 34.997 36.591 73.767 26.223 37.459
Shareholders Funds - - -2.405 5.688 28.398 43.841 83.403 136.147 132.197 185.928
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 9.073 12.032 6.481 825 1.638 235 3.507 14.840
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4638 - 4638"
CAEN Financial Year 4638
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 185.489 euro in 2023 which includes Inventories of 36.313 euro, Receivables of 111.716 euro and cash availability of 37.459 euro.
The company's Equity was valued at 185.928 euro, while total Liabilities amounted to 14.840 euro. Equity increased by 54.132 euro, from 132.197 euro in 2022, to 185.928 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Bioaccent Srl

Comments - Bioaccent Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.